Posts in M&A
AbbVie's purchase of Allergan expands patent scope | IAM

AbbVie’s $63 billion bid for Allergan has just received final approval from the European Commission and is now awaiting word from the US Federal Trade Commission (FTC), which is still reviewing the pending transaction. The tie-up, as covered by IAM, has been described as a short-term solution for AbbVie which is preparing for the loss of exclusivity of its key brand Humira in 2023.

ACCESS

Read More
Sanofi eyes more M&A as deals drive increase in IP portfolio quality | IAM

Sanofi announced a $3.4 billion deal to purchase US biotech company Principia Biopharma. It’s the third-largest pharmaceutical acquisition of 2020 and the company’s second big ticket deal since Paul Hudson joined as CEO in September 2019. The former Novartis executive has made his priorities at Sanofi clear: cut costs and invest in innovative - and lucrative - medicines.

ACCESS

Read More
Foxconn and Sharp – a patent strategy marriage made in heaven | IAM

Foxconn, also known as Hon Hai Precision (its parent company), has long been celebrated as a leading player in the IP community. Under chairman Terry Gou’s savvy guidance, the company has built a robust patent portfolio with recognised clout in the US as well as other key jurisdictions. In 2016, when Foxconn acquired Sharp for a cool $3.8 billion, there were questions over how the company would deploy the IP that came with it.

ACCESS

Read More
Presentation on M&A in Asia

M&A transactions are on the rise in Asia and Asian companies are playing an increasing role in the M&A market. However, it can be challenging to identify company strategies and evolving trends in M&A. See the evolution of the patent portfolios of major companies in Asia - such as Softbank, Alibaba and Foxconn, analyses of M&A transactions and insight on the transitions.

ACCESS

Read More
Fujitsu Pursued by Chinese Companies

Xiaomi's approach to catching up technologically is simple: get patent licenses, or acquire companies and technologies. Xiaomi has the rights to roughly 617 patents in the US, and 62% of these were transferred from outside rights holders. In order to compare Xiaomi's technological position with that of Fujitsu, Japan's leading telecommunications manufacturer, we created a panoramic chart using...

ACCESS

Read More